| Literature DB >> 26059079 |
Julianne L Holloway1, Henry Ma1, Reena Rai1, Kurt D Hankenson2, Jason A Burdick3.
Abstract
In order to achieve bone repair, bone morphogenetic protein-2 (BMP-2) is typically delivered in non-physiological doses and can result in significant adverse side effects. To reduce the amount of BMP-2 necessary for bone formation, we delivered a known chemokine (stromal cell derived factor-1α, SDF-1α) in combination with BMP-2 using proteolytically degradable hydrogels. A critical-sized calvarial defect was used to determine the effect of biomolecule delivery on bone formation in vivo. The treatment group with combined SDF-1α and BMP-2 hydrogel delivery showed significantly higher bone formation when compared to hydrogels loaded with the same BMP-2 or SDF-1α concentrations alone, suggesting the combined delivery of both biomolecules synergistically improves osteogenesis.Entities:
Keywords: bone morphogenetic protein; bone tissue engineering; drug delivery; hyaluronic acid; hydrogel; stromal cell-derived factor-1α
Mesh:
Substances:
Year: 2015 PMID: 26059079 PMCID: PMC4558375 DOI: 10.1002/mabi.201500178
Source DB: PubMed Journal: Macromol Biosci ISSN: 1616-5187 Impact factor: 4.979